Hartford Funds Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,283
Closed -$662K 102
2024
Q4
$662K Buy
8,283
+201
+2% +$17.4K 0.06% 68
2024
Q3
$728K Buy
8,082
+305
+4% +$25.7K 0.07% 57
2024
Q2
$612K Buy
7,777
+579
+8% +$47.5K 0.06% 64
2024
Q1
$627K Buy
7,198
+1,189
+20% +$101K 0.06% 56
2023
Q4
$495K Buy
6,009
+1,505
+33% +$115K 0.05% 57
2023
Q3
$353K Buy
4,504
+378
+9% +$31.6K 0.04% 55
2023
Q2
$364K Buy
4,126
+450
+12% +$38.7K 0.04% 55
2023
Q1
$296K Buy
3,676
+700
+24% +$57.1K 0.03% 57
2022
Q4
$231K Buy
+2,976
New +$241K 0.02% 64

Other funds holding MDT

Hartford Funds Management's MDT Position: Q1 2025 in Review

Hartford Funds Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 8,283 shares — an estimated $662K sold.

Hartford Funds Management first reported a position in MDT in Q4 2022 and held it in 9 quarters. The position peaked at $728K in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Hartford Funds Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Hartford Funds Management sold 8,283 Medtronic shares in Q1 2025, an estimated $662K.
  • Hartford Funds Management first reported a position in Medtronic in Q4 2022 and held it in 9 quarters.
  • Hartford Funds Management's Medtronic position peaked at $728K in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Hartford Funds Management's 13F filing for Q1 2025, filed 6 May 2025.